Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,323 total articles

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Health Catalyst, a healthcare intelligence company listed on Nasdaq as HCAT, announced it will release its first quarter 2026 operating results after market close on May 11, 2026, followed by a conference call to discuss the results. The company specializes in AI-driven healthcare data analytics aimed at improving health system performance.

reAlpha (Nasdaq: AIRE) CEO and CFO to Present Company's Vertically Integrated Homebuying Vision at Two New York Conferences

reAlpha (Nasdaq: AIRE) CEO and CFO to Present Company's Vertically Integrated Homebuying Vision at Two New York Conferences

reAlpha Tech Corp., a Nasdaq-listed AI-powered real estate technology company, announced upcoming presentations by CEO Mike Logozzo and CFO Thomas Kutzman at two New York investor conferences. The company will discuss its strategic progress in building a vertically integrated platform that combines real estate brokerage, mortgage, and title service…

IES Holdings Reports Fiscal 2026 Second Quarter Results

IES Holdings Reports Fiscal 2026 Second Quarter Results

IES Holdings, Inc. reported strong financial results for its second quarter ending March 31, 2026, highlighting 17% revenue growth to $974 million and a 21% increase in operating income year-over-year. The company notably completed the acquisition of Gulf Island Fabrication, significantly bolstering its Infrastructure Solutions segment. Driven by r…

Gildan Activewear Reports on Shareholders’ Voting Results

Gildan Activewear Reports on Shareholders’ Voting Results

Gildan Activewear Inc. held its annual shareholders meeting, where all nine director nominees were duly elected. Shareholders also approved the reappointment of the company's auditor, the renewal of the Shareholder Rights Plan, and supported the executive compensation advisory vote ('Say on Pay'). These results reflect strong shareholder confidence…

InflaRx to Report First Quarter 2026 Results on May 7, 2026

InflaRx to Report First Quarter 2026 Results on May 7, 2026

InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, announced it will report its first quarter 2026 financial and operating results on May 7, 2026, before the market opens. The company highlighted its lead drug candidates, izicopan and vilobelimab, both targeting the C5a and C5a …

Stock Yards Bancorp Completes Acquisition of Field & Main Bancorp

Stock Yards Bancorp Completes Acquisition of Field & Main Bancorp

Stock Yards Bancorp, Inc. (NASDAQ: SYBT) has completed its acquisition and merger of Field & Main Bancorp, Inc. The merger expands Stock Yards' presence in Western Kentucky and extends its access in Kentucky, Indiana, and Ohio markets. Field & Main's customers will maintain current banking services during integration, which is expected to be comple…

Griffin Seafoot Named Champions of Tomorrow Scholarship Recipient by Papa Johns Canada and the CHL

Griffin Seafoot Named Champions of Tomorrow Scholarship Recipient by Papa Johns Canada and the CHL

Papa Johns Canada and the Canadian Hockey League have awarded the Champions of Tomorrow Scholarship to young hockey player Griffin Seafoot, recognizing his leadership, academic excellence, and community service. The $25,000 scholarship highlights Papa Johns’ community engagement and partnership with the CHL, focusing on youth development through sp…

Rekor Systems to Announce First Quarter Fiscal 2026 Results

Rekor Systems to Announce First Quarter Fiscal 2026 Results

Rekor Systems, Inc., a NASDAQ-listed company specializing in AI-driven roadway intelligence solutions, announced the release date for its first quarter fiscal 2026 financial results. The company will hold a conference call on May 11, 2026, to discuss its financial and operational performance. The announcement includes details for participating in t…

Esperion to be Acquired by ARCHIMED

Esperion to be Acquired by ARCHIMED

Esperion Therapeutics, a biopharmaceutical company specializing in cardiometabolic and rare disease therapies, agreed to be acquired by ARCHIMED in a transaction worth up to $1.1 billion. Esperion shareholders will receive $3.16 per share in cash plus potential milestone payments tied to future sales. The deal offers a significant premium and posit…

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

MapLight Therapeutics, a clinical-stage biopharmaceutical company focused on central nervous system disorders, announced the completion of enrollment in the ZEPHYR Phase 2 trial for schizophrenia and the final patient visit in the IRIS Phase 2 trial for autism spectrum disorder. The company expects topline results from both trials by mid-August 202…

OIO Group Announces New Leadership, Board Appointments and Strategic Roadmap for Ultra-Luxury Mobility Platform

OIO Group Announces New Leadership, Board Appointments and Strategic Roadmap for Ultra-Luxury Mobility Platform

Following its business combination with De Tomaso Automobili, OIO Group announces its new board and executive team, outlining a strategy focused on ultra-luxury automotive marques, specialist engineering, and collector-driven programmes. The company aims to build a differentiated platform emphasizing rarity, craftsmanship, and brand authenticity to…

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Molecular Partners announced the publication of positive Phase 1 clinical trial data for MP0317, a tumor-localized CD40 agonist, demonstrating effective tumor microenvironment modulation and a favorable safety profile in advanced cancer patients. The data support further clinical trials, including an ongoing Phase 2 study in cholangiocarcinoma, com…

Perella Weinberg Reports First Quarter 2026 Results

Perella Weinberg Reports First Quarter 2026 Results

Perella Weinberg Partners reported Q1 2026 revenues of $149 million, a 30% decline from last year, resulting in a GAAP pre-tax loss of $11 million. Despite lower revenues driven by fewer fee-paying clients and reduced deal closings, the firm made strategic acquisitions and expanded senior talent, including the addition of Gleacher Shacklock to incr…

Brookfield Renewable Reports Record First Quarter Results

Brookfield Renewable Reports Record First Quarter Results

Brookfield Renewable announced record first quarter 2026 financial results, including a 19% increase in Funds From Operations (FFO) year-over-year. The company highlighted the acquisition of Canadian renewable energy platform Boralex, adding substantial operating capacity and a large development pipeline. Growth driven by strong performance in hydr…